CVS replaces CEO, pulls profit forecast as investor pressure mounts

Published On Oct 18, 2024, 8:22 AM

CVS Health has replaced its CEO, Karen Lynch, amid increasing pressure from investors and has withdrawn its profit forecast for 2024. The company announced that David Joyner, a veteran at CVS, would take over as CEO. CVS reported that its third-quarter adjusted profit expectations are significantly below analysts' estimates, leading to an 11% drop in share price during premarket trading. This decline follows multiple profit forecast reductions due to higher operational costs and decreased reimbursement rates affecting its drugstore business.

Read full article

Stock Forecasts

CVSView CVS chart on TradingView

Negative

CVS is facing significant challenges due to leadership changes and a bleak profit outlook, which has led to a substantial drop in share price. Investors may want to consider the long-term implications of these leadership transitions and ongoing operational challenges before investing. The situation may stabilize in the future, but right now, it appears negative for the stock.

Related News

Why neighborhood pharmacies are closing

Oct 18, 2024, 6:00 AM

Retail pharmacies will never be obsolete, according to an analyst. But the industry needs to take a hard look at how many stores are needed and what items they should sell.

CVS
WBA

'Barron's Roundtable' gives CVS outlook amid calls of a breakup | Fox Business Video

'Barron's Roundtable' panelists discuss calls of a breakup for CVS prompting a strategic review.

CVS

Port strike incites panic buying as consumers feared supply chain issues

Oct 4, 2024, 6:00 AM

Panic buying ensued in some U.S. stores after dockworkers at ports along the East and Gulf coasts went on a three-day strike that ended on Thursday evening.

WMT
CVS